Health Care & Life Sciences

Lilly eyes more animal-health acquisitions

March 25, 2010
 IBJ Staff and Bloomberg News
Eli Lilly is interested in assets that may be offered for sale as a result of Sanofi-Aventis SA and Merck & Co.'s plan to combine their veterinary units.
More

Conseco seeking to change its name

March 25, 2010
 IBJ Staff and Bloomberg News
Carmel-based insurer Conseco Inc. will ask shareholders to approve changing the company’s name to CNO Financial Group, the company said Thursday morning.
More

Daniels warns of health bill's 'immorally huge' taxes

March 25, 2010
Associated Press
Daniels told members of the Economic Club of Indianapolis that it's ridiculous for anyone to suggest the nearly $1 trillion health care overhaul signed into law Tuesday by President Barack Obama won't add to the nation's debt.
More

Lilly sues Hospira over generic version of Gemzar

March 24, 2010
Bloomberg News
Indianapolis-based Eli Lilly and Co. sued rival drugmaker Hospira Inc. to prevent it from selling a generic version of the cancer drug Gemzar before a patent on the medicine expires in 2013.
More

Docs fear reform will exacerbate ER overuse

March 24, 2010
J.K. Wall
One of the most agreed-upon reasons for health care reform was the expensive overuse of the emergency room by uninsured patients. But two Hoosier ER docs—one conservative, one liberal—say the implementation of ObamaCare will leave that fundamental problem unresolved.
More

IU study: Money matters to docs

March 24, 2010
J.K. Wall

Think doctors and hospitals aren’t influenced by money? Think again. Patients seen at private facilities reimbursed by Medicare were 5.5 times more likely to receive routine cataract surgery than patients at poorly funded Veterans Affairs facilities.

More

Obama signs historic $938 billion health care overhaul

March 23, 2010
Associated Press
Attorneys general from 13 states filed suit to stop the overhaul just minutes after the bill signing, contending the law is unconstitutional. Other state attorneys general may join the lawsuit later or sue separately.
More

Ariad loses $65M patent appeal against Eli Lilly

March 22, 2010
Bloomberg News
Monday's decision throws out a $65.2 million patent-infringement verdict won by Ariad for royalties on Lilly's osteoporosis drug Evista and sepsis medicine Xigris.
More

State attorney general looks to challenge health care bill

March 22, 2010
Associated Press
Attorneys general in at least 13 states have signaled they intend to challenge the constitutionality of the legislation in court.
More

Bill kicks off years of change for local health care players

March 22, 2010
J.K. Wall
Sweeping changes phase in slowly for most, but insurers, hospitals, drug companies, employers, workers, medical device makers and more will eventually feel impact.
More

Reform offers risk, opportunities for Lilly, WellPoint

March 22, 2010
 IBJ Staff and Bloomberg News
Drugmakers and insurers could gain millions of customers under the legislation, but the industry also will pay new fees and face stricter rules that may shrink profit and fuel mergers.
More

Congress passes historic health care bill

March 21, 2010
Associated Press
To pay for the changes, the legislation includes more than $400 billion in higher taxes over a decade, roughly half of it from a new Medicare payroll tax on individuals with incomes over $200,000 and couples over $250,000.
More

Indiana food manufacturers ramp up safety precautions

March 20, 2010
Kathleen McLaughlin
The peanut-borne salmonella outbreak of 2009 raised awareness about the risk of illness from unlikely sources. Unfortunately, that wasn’t the last time a seemingly innocuous ingredient made people sick, and prompted recalls.
More

Simon Property Group adds Glasscock to board

March 18, 2010
 IBJ Staff and Associated Press
Former WellPoint Inc. leader Larry Glasscock has joined the board of directors of the Indianapolis-based real estate giant.
More

Lilly sues to block generic of Adcirca lung treatment

March 17, 2010
Bloomberg News
Netherlands-based Synthon Pharmaceuticals is seeking U.S. Food and Drug Administration approval to sell a copy of the medicine.
More

IU incubator attracts East Coast biotech startup

March 17, 2010
 IBJ Staff
Companion Diagnostics Inc. moves from Connecticut to the IU Emerging Technologies Center, hopes to create 30 high-paying jobs by 2014.
More

WellPoint expects loss of 400,000 insured members this year

March 17, 2010
 IBJ Staff and Bloomberg News
Indianapolis-based health insurer expects revenue, profit to fall as persistently high unemployment reduces employer-sponsored insurance enrollment.
More

Indiana health groups dial back lobbying

March 17, 2010
J.K. Wall
Indiana health-related companies were somewhat absent from the lobbying bonanza that gripped Washington, D.C., in 2009. For all the heat and light about health reform, major Indiana companies actually spent slightly less to lobby Congress.
More

Wishard debt $80M below 'best' scenario

March 17, 2010
J.K. Wall
Historically low bond rates will help the parent corporation of Wishard Health Services build hospital for less money than expected.
More

St. Francis acquires orthopedic surgery practice

March 16, 2010
J.K. Wall
St. Francis Hospital & Health Centers has acquired Joint Replacement Surgeons of Indiana, a six-doctor practice that operates in St. Francis' Mooresville hospital.
More

Lilly victim of theft from Connecticut warehouse

March 16, 2010
 IBJ Staff and Associated Press
Pharmaceuticals stolen Sunday morning could be worth up to $75 million.
More

Lilly pays $50M-plus for rights to testosterone lotion

March 16, 2010
Bloomberg News
Indianapolis-based Lilly will pay Acrux of West Melbourne, Australia, a $50 million license fee, plus $3 million when manufacturing assets are transferred, but the deal could be worth millions more.
More

WellPoint affiliate ordered to pay $206K for transplant

March 16, 2010
Associated Press
Blue Cross of California has been ordered to reimburse a man $206,000 after he paid for his own liver transplant.
More

Community Health Network Foundation names new CEO

March 15, 2010
 IBJ Staff
Michele Thomas Dole has been a wealth adviser at JP Morgan Chase and development director of the IU Foundation.
More

FDA says 'not yet' on Lilly's once-weekly Byetta

March 15, 2010
J.K. Wall
Regulators won't require more time-consuming tests of the drug, but want Eli Lilly and Co. and its partners to clarify labeling, manufacturing processes.
More
Page  << 71 72 73 74 75 76 77 78 79 80 >> pager
Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
ADVERTISEMENT